成人肠易激综合征患者的营养干预:随机临床试验的系统评价和荟萃分析的伞状评价

Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials.

作者信息

Zeraattalab-Motlagh Sheida, Ranjbar Mahsa, Mohammadi Hamed, Adibi Peyman

机构信息

Department of Health and Human Performance, University of Houston, Houston, TX 77204, United States.

Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran 1417613151, Iran.

出版信息

Nutr Rev. 2025 Mar 1;83(3):e1343-e1354. doi: 10.1093/nutrit/nuae107.

Abstract

CONTEXT

There is still debate regarding the effect of nutritional interventions in improving irritable bowel syndrome (IBS) symptoms.

OBJECTIVES

The aim was to examine the evidence certainty and validity of all existing meta-analyses of intervention trials on nutritional interventions in patients with IBS.

DATA SOURCES

Scopus, PubMed, and Web of Science were reviewed until June 2023.

DATA EXTRACTION

Meta-analyses assessing the impacts of nutritional interventions in adults with IBS were entered. Effect sizes of nutritional interventions were recalculated by applying a random-effects model. GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) was implemented to determine evidence certainty.

RESULTS

A total of 175 trials in 58 meta-analyses were entered describing the effects of 11 nutritional interventions on IBS-related outcomes. Nutritional interventions had beneficial effects on some IBS-related outcomes. For instance, soluble fiber, peppermint oil, and aloe vera improved IBS symptoms, and vitamin D3 and curcumin improved IBS symptom severity. Tongxieyaofang improved abdominal pain severity and stool frequency. Nevertheless, these outcomes have mainly shown small effects and low to very low evidence certainty. With regard to abdominal pain after probiotic supplementation (relative risk [RR]: 4.04; 95% confidence interval [CI]: 2.36, 6.92; GRADE = moderate) and IBS symptoms after a low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (RR: 1.48; 95% CI: 1.14, 1.93; GRADE = moderate), there was evidence that probiotics and a low-FODMAP diet can confer clinical and favorable effects.

CONCLUSION

The current review does not support nutritional interventions for improving IBS symptoms. With regard to probiotics and a low-FODMAP diet, considering limitations like short-term study duration, there was an influential clinical impact.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO registration no. CRD42023429991.

摘要

背景

关于营养干预对改善肠易激综合征(IBS)症状的影响仍存在争议。

目的

旨在审查所有现有关于IBS患者营养干预的干预试验的荟萃分析的证据确定性和有效性。

数据来源

对Scopus、PubMed和Web of Science进行检索,直至2023年6月。

数据提取

纳入评估营养干预对成年IBS患者影响的荟萃分析。采用随机效应模型重新计算营养干预的效应量。运用GRADE(推荐分级、评估、制定与评价)来确定证据确定性。

结果

58项荟萃分析中共有175项试验纳入,描述了11种营养干预对IBS相关结局的影响。营养干预对一些IBS相关结局有有益作用。例如,可溶性纤维、薄荷油和芦荟改善了IBS症状,维生素D3和姜黄素改善了IBS症状严重程度。痛泻要方改善了腹痛严重程度和大便频率。然而,这些结局主要显示出较小的效果以及低至极低的证据确定性。关于补充益生菌后的腹痛(相对风险[RR]:4.04;95%置信区间[CI]:2.36,6.92;GRADE = 中等)以及低可发酵寡糖、双糖、单糖和多元醇(FODMAP)饮食后的IBS症状(RR:1.48;95%CI:1.14,1.93;GRADE = 中等),有证据表明益生菌和低FODMAP饮食可产生临床和有益效果。

结论

当前综述不支持采用营养干预来改善IBS症状。关于益生菌和低FODMAP饮食,考虑到研究持续时间短等局限性,存在有影响力的临床影响。

系统评价注册

PROSPERO注册号CRD42023429991。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索